MIRA INFORM REPORT

 

 

Report Date :

17.09.2014

 

IDENTIFICATION DETAILS

 

Name :

R.N. LABORATORIES PRIVATE LIMITED

 

 

Formerly Known As :

SKY CHEM PRIVATE LIMITED

 

 

Registered Office :

404, VIP Plaza, Off Link Road, Andheri (West), Mumbai – 400053, Maharashtra

 

 

Country :

India

 

 

Financials (as on) :

31.03.2012

 

 

Date of Incorporation :

04.12.1998

 

 

Com. Reg. No.:

11-117339

 

 

Capital Investment / Paid-up Capital :

Rs. 0.101 Million

 

 

CIN No.:

[Company Identification No.]

U24200MH1998PTC117339

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

MUMR20663G

 

 

PAN No.:

[Permanent Account No.]

AAECS2969P

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Manufacturer and Exporter of Pharma Products. 

 

 

No. of Employees :

Not Divulged

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba (45)

 

RATING

STATUS

 

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

 

Maximum Credit Limit :

USD 400

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

Usually Correct

 

 

Litigation :

Clear 

 

 

Comments :

Subject is an established company having satisfactory track record.

 

The management has failed to file its financial record with government department for the year 2013.

 

As per available financial of 2012, the ratings reflect the extensive experience of RNLPL’s promoters in the pharmaceutical industry supported by above-average financial risk profile and fair liquidity position of the company.

 

Trade relations are fair. Business is active. Payment terms are reported to be usually correct.

 

The company can be considered for business dealings at usual trade terms and condition. 

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – June 1, 2014

 

Country Name

Previous Rating

(31.03.2014)

Current Rating

(01.06.2014)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

INDIAN ECONOMIC OVERVIEW

 

N E W S

 

Verdict Implications : Apex court order may alter coal import dynamics. Traders go slow on talks over coal supply contracts, uncertainty over cancellation of blocks weigh on stocks.

 

Recent arrest of the Chennai head of the Registrar of Companies, the ministry of corporate affairs arm that ensures that companies file all the information required by the Companies Act is the latest manifestation of a messy fight between a father and his adopted son for the control of Rs 40000 mn business empire. The Central Bureau of Investigation arrested Manumeethi Cholan after he accepted Rs 10 lakhs as bribe from M A M Ramaswamy, a CBI official said.

 

Central Bureau of Investigation books Electrotherm for cheating Central Bank of Rs 4360 mn.

 

Infosys maintains revenue guidance. COO Rao says attrition still an area of concern and it would take a few more quarters to bring down levels to 13-15 %.

 

DHL  to invest Euro 100 mn in India over next 2 years. The firm has chosen India to pilot its e-commerce business model for the Asia-Pacific region.

 

Blackstone may buy stake in BlueRidge SEZ in line with the fund’s real estate strategy in India.

 

Kingfisher Airlines Ltd grounded in October 2012 under the weight of heavy debt and accumulated losses, recently approached the Delhi high court for relief in two separate cases. The airline challenged a notice by Punjab & National Bank alleging that It had wilfully defaulted on Rs 7700 mn of loans and sought more time to comply with the requirements under the listing agreements with the Stock Exchanges.

 

OnMobile likely to sack another 300 employees. The lay-offs follow a spate of senior-level exits over the past two years, starting with of its founder. The overall lay-offs could number around 600 and are driven by the need to cut costs, says a former employee.

 

 

EXTERNAL AGENCY RATING

 

Rating Agency Name

CRISIL

Rating

Long term rating : BBB

Rating Explanation

Moderate degree of safety and moderate credit risk.

Date

June 18, 2014

 

 

Rating Agency Name

CRISIL

Rating

Short term rating : A3+

Rating Explanation

Moderate degree of safety and higher credit risk.

Date

June 18, 2014

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2014.

 

 

INFORMATION DENIED

 

MANAGEMENT NON CO-OPERATIVE (91-22-26736664)

 

 

LOCATIONS

 

Registered Office :

404, VIP Plaza, Off Link Road, Andheri (West), Mumbai – 400053, Maharashtra, India

Tel. No.:

91-22-26736664

Fax No.:

91-22-26736643

E-Mail :

mpin@vsnl.net

rnpin@vsnl.net

accounts@rnpharma.com 

rohit@rnpharma.com

sales.rnlab@gmail.com

sales@rnlaboratories.com

Website :

http://www.rnlaboratories.com

Location :

Owned

 

 

Admin Office :

Plot No. 1 and 86 (Surat SEZ), Survey No. 327/P and 278/P, Village Sachin, Near Sachin Railway Station, Diamond Park, Sachin, District Surat - 394230, Gujarat, India  

 

 

 

 

Factory :

Plot No. 117 and 138, Surat SEZ, Near Sachin GIDC, Village Sachin, Taluka Choryasi, Surat – 394230, Gujarat, India

Location :

Owned

 

 

DIRECTORS

 

AS ON 28.09.2012

 

Name :

Mr. Rohit Shamlal Garg

Designation :

Director

Address :

2-B, 171, Classique Building, New Link Road, Andheri (West), Mumbai – 400053, Maharashtra, India

Date of Appointment :

04.12.1998

DIN No.:

00700594

Other Directorship :

 

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Company/ LLP Status

Defaulting status

1

U24200MH1998PTC117339

R.N. LABORATORIES PRIVATE LIMITED

Director

04/12/1998

04/12/1998

Active

NO

2

U24233MH2011PTC224152

R.N. DRUGS PRIVATE LIMITED

Director

19/11/2011

19/11/2011

Active

NO

 

 

Name :

Mr. Nitin Shamlal Garg

Designation :

Director

Address :

1720/1721, Raheja Classique, New Link Road, Andheri (West), Mumbai – 400053, Maharashtra, India

Date of Appointment :

04.12.1998

DIN No.:

02430137

Other Directorship :

 

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Company/ LLP Status

Defaulting status

1

U24200MH1998PTC117339

R.N. LABORATORIES PRIVATE LIMITED

Director

04/12/1998

04/12/1998

Active

NO

2

U24233MH2011PTC224152

R.N. DRUGS PRIVATE LIMITED

Director

19/11/2011

19/11/2011

Active

NO

 

 

Name :

Mr. Sham Lal Garg

Designation :

Director

Address :

2B/12, Sea Palace Society Juhu Tara Road, Santacruze (West), Mumbai – 400049, Maharashtra, India

Date of Appointment :

04.12.1998

DIN No.:

02887465

 

 

KEY EXECUTIVES

 

Name :

Mr. Rahul

Designation :

Finance Manager

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

AS ON 28.09.2012

 

Names of Shareholders

No. of Shares

%age

Nitin Shamlal Garg

500

49.50

Rohit Shamlal Garg

500

49.50

Shamlal Garg

10

0.99

 

 

 

Total

1010

100.00

 

 

 

AS ON 28.09.2012

 

Equity Share Breakup

Percentage of Holding

Category

 

Directors or relatives of directors

100.00

 

 

Total

 

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer and Exporter of Pharma Products. 

 

 

GENERAL INFORMATION

 

No. of Employees :

Not Divulged

 

 

Bankers :

Bank of India, Andheri (West) Branch, Bank of India Building, Mumbai - 400058, Maharashtra, India

 

 

Facilities :

 

SECURED LOANS

31.03.2012

(Rs. In Millions)

31.03.2011

(Rs. In Millions)

SHORT TERM BORROWINGS

 

 

Working Capital from Bank

(Secured against hypothecation of stock and debtors)

47.673

19.149

 

 

 

Total

 

47.673

19.149

 

 

 

Banking Relations :

--

 

 

Auditors :

 

Name :

R.A. Kuvadia and Company

Chartered Accountants

Address :

1/7, Chaitanya Society, Vakola Bridge, Santacruz (East), Mumbai – 400055, Maharashtra, India

Tel. No.:

91-22-26681719

Fax No.:

91-22-26680488

E-Mail :

rashmikantca@yahoo.co.in

Income-tax PAN of auditor or auditor's firm :

AAHPL0055A

 

 

Sister Concerns :

·         R.N. Pharma

·         R.N. Investment

 

 

CAPITAL STRUCTURE

 

 

After 28.09.2012

 

Authorised Capital : Rs. 100.000 Millions

 

 

Issued, Subscribed & Paid-up Capital : Rs. 100.000 Millions

 

 

AS ON 31.03.2012

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

10,000

Equity Shares

Rs. 100/- each

Rs. 1.000 Million

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

1,010

Equity Shares

Rs. 100/- each

Rs. 0.101 Million

 

 

 

 

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

 

31.03.2012

31.03.2011

I.        EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

 

0.101

0.101

(b) Reserves & Surplus

 

156.731

86.565

(c) Money received against share warrants

 

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

 

0.620

0.620

Total Shareholders’ Funds (1) + (2)

 

157.452

87.286

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

 

0.000

0.000

(b) Deferred tax liabilities (Net)

 

1.380

0.318

(c) Other long term liabilities

 

0.000

0.000

(d) long-term provisions

 

0.000

0.000

Total Non-current Liabilities (3)

 

1.380

0.318

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

 

49.232

38.630

(b) Trade payables

 

36.527

47.338

(c) Other current liabilities

 

2.330

1.144

(d) Short-term provisions

 

15.632

0.355

Total Current Liabilities (4)

 

103.721

87.467

 

 

 

 

TOTAL

 

262.553

175.071

 

 

 

 

II.    ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

 

110.877

56.144

(ii) Intangible Assets

 

0.000

0.000

(iii) Capital work-in-progress

 

25.000

24.809

(iv) Intangible assets under development

 

0.000

0.000

(b) Non-current Investments

 

0.000

0.000

(c) Deferred tax assets (net)

 

0.000

0.000

(d)  Long-term Loan and Advances

 

5.394

5.118

(e) Other Non-current assets

 

0.000

0.000

Total Non-Current Assets

 

141.271

86.071

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

 

0.000

0.000

(b) Inventories

 

32.072

39.936

(c) Trade receivables

 

75.856

45.173

(d) Cash and cash equivalents

 

6.574

2.636

(e) Short-term loans and advances

 

6.779

1.222

(f) Other current assets

 

0.001

0.033

Total Current Assets

 

121.282

89.000

 

 

 

 

TOTAL

 

262.553

175.071

 

 

SOURCES OF FUNDS

 

 

 

31.03.2010

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

 

 

0.101

2] Share Application Money

 

 

0.620

3] Reserves & Surplus

 

 

88.191

4] (Accumulated Losses)

 

 

0.000

NETWORTH

 

 

88.912

LOAN FUNDS

 

 

 

1] Secured Loans

 

 

6.700

2] Unsecured Loans

 

 

1.272

TOTAL BORROWING

 

 

7.972

DEFERRED TAX LIABILITIES

 

 

0.249

 

 

 

 

TOTAL

 

 

97.133

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

 

 

52.305

Capital work-in-progress

 

 

0.000

 

 

 

 

INVESTMENT

 

 

0.000

DEFERRED TAX ASSETS

 

 

0.000

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

 
 
7.418

 

Sundry Debtors

 
 
27.277

 

Cash & Bank Balances

 
 
0.415

 

Other Current Assets

 
 
0.000

 

Loans & Advances

 
 
32.860

Total Current Assets

 
 
67.970

Less : CURRENT LIABILITIES & PROVISIONS

 
 

 

Sundry Creditors

 
 

 

 

Other Current Liabilities

 
 

22.708

 

Provisions

 
 

0.434

Total Current Liabilities

 
 
23.142

Net Current Assets

 
 
44.828

 

 

 

 

MISCELLANEOUS EXPENSES

 

 

0.000

 

 

 

 

TOTAL

 

 

97.133

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

 

31.03.2012

31.03.2011

31.03.2010

 

SALES

 

 

 

 

 

TOTAL                                    

360.000

(Approximately)

NA

NA

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

TOTAL                                    

NA

NA

NA

 

 

 

 

 

 

PROFIT BEFORE TAX

NA

NA

49.914

 

 

 

 

 

Less

TAX                                                                 

NA

NA

0.184

 

 

 

 

 

 

PROFIT AFTER TAX

NA

NA

49.730

 

 

 

 

 

 

Earnings Per Share (Rs.)

NA

NA

49237.62

 

 

Particulars

 

 

 

31.03.2013

Sales Turnover (Approximately)

 

 

460.000

 

 

 

 

 

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2012

31.03.2011

31.03.2010

Return on Total Assets

(PBT/Total Assets}

(%)

NA

NA

41.50

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

NA

NA

0.57

 

 

 

 

 

Debt Equity Ratio

(Total Debt/Networth)

 

0.31

0.44

0.09

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

1.17

1.02

2.94

 

 

FINANCIAL ANALYSIS

[all figures are in Rupees Millions]

 

DEBT EQUITY RATIO

 

Particular

31.03.2011

31.03.2012

 

(Rs. In Millions)

(Rs. In Millions)

Share Capital

0.101

0.101

Reserves & Surplus

86.565

156.731

Net worth

86.666

156.832

 

 

 

long-term borrowings

0.000

0.000

Short term borrowings

38.630

49.232

Total borrowings

38.630

49.232

Debt/Equity ratio

0.446

0.314

 

 

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check List by Info Agents

Available in Report

(Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

No

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

No

9]

Name of person contacted

No

10]

Designation of contact person

No

11]

Turnover of firm for last two years

Yes

12]

Profitability for last one year

Yes

13]

Reasons for variation <> 20%

--

14]

Estimation for coming financial year

No

15]

Capital in the business

Yes

16]

Details of sister concerns

Yes

17]

Major suppliers

No

18]

Major customers

No

19]

Payments terms

No

20]

Export / Import details (if applicable)

No

21]

Market information

--

22]

Litigations that the firm / promoter involved in

--

23]

Banking Details

Yes

24]

Banking facility details

Yes

25]

Conduct of the banking account

--

26]

Buyer visit details

--

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

No

30]

Major Shareholders, if available

Yes

31]

Date of Birth of Proprietor/Partner/Director, if available

Yes

32]

PAN of Proprietor/Partner/Director, if available

No

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

Yes

 

 

 

INDEX OF CHARGES

 

S.NO.

CHARGE ID

DATE OF CHARGE CREATION/MODIFICATION

CHARGE AMOUNT SECURED

CHARGE HOLDER

ADDRESS

SERVICE REQUEST NUMBER (SRN)

1

10203521

10/12/2012 *

160,000,000.00

BANK OF INDIA

ANDHERI (WEST) BRANCH, BANK OF INDIA BUILDING, G ROUND FLOOR, 28, S. V. ROAD, ANDHERI (WEST), MUMBAI - 400058, MAHARASHTRA, INDIA

B65484487

2

10204376

10/12/2012 *

160,000,000.00

BANK OF INDIA

ANDHERI (WEST) BRANCH, BANK OF INDIA BUILDING, G ROUND FLOOR, 28, S. V. ROAD, ANDHERI (WEST), MUMBAI - 400058, MAHARASHTRA, INDIA

B65483539

3

10193858

17/11/2009

5,000,000.00

BANK OF INDIA

ANDHERI (WEST) BRANCH, BANK OF INDIA BUILDING, G ROUND FLOOR, 28, S. V. ROAD, ANDHERI (WEST), MUMBAI - 400058, MAHARASHTRA, INDIA

A76460906

 

* Date of charge modification

 

 

UNSECURED LOANS

 

UNSECURED LOANS

31.03.2012

(Rs. In Millions)

31.03.2011

(Rs. In Millions)

SHORT TERM BORROWINGS

 

 

Loan from Directors

1.261

19.481

Loan from Related Party

0.298

0.000

 

 

 

Total

 

1.559

19.481


TRADE REFERENCES:

 

·         Hebei Medipharm Company Limited, China

Unilab Chemicals and Pharmaceuticals Private Limited, Mumbai


 

CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                              None

 

5]         on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs. 60.99

UK Pound

1

Rs. 99.10

Euro

1

Rs. 79.03

 

 

INFORMATION DETAILS

 

Information Gathered by :

HTL

 

 

Analysis Done by:

KAR

 

 

Report Prepared by :

ANK

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

5

PAID-UP CAPITAL

1~10

5

OPERATING SCALE

1~10

5

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

5

--PROFITABILIRY

1~10

5

--LIQUIDITY

1~10

5

--LEVERAGE

1~10

5

--RESERVES

1~10

5

--CREDIT LINES

1~10

5

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

NO

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTERS 

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

TOTAL

 

45

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.